BB Biotech AG (BION.SW) — Quality & forensics
As of 2026-09-18 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 81
- Quality 95
- Growth 78
- Balance sheet 88
- Cash quality 16
- Capital allocation 50
- Momentum 73
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Continue: the BION.SW chart & overview
FAQ · from the current data · as of 2026-09-18
Quick answers
What is BB Biotech AG's Closelook quality reading?
The composite reads 74/100 across 7 modules, as of 2026-09-18: valuation 81, quality 95, growth 78, balance sheet 88, cash quality 16, capital allocation 50, momentum 73. Closelook scores are research diary readings, not ratings or investment advice.
What is BB Biotech AG's Piotroski F-Score?
4 of 7, as of 2026-09-18. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
Related in the Closelook universe
- 0B2.DE Bawag Group AG
- 0ZC.DE ZSCALER INC. DL-,001
- 1N8.DE ADYEN N.V. EO-01
- 2NN.DE NN Group N.V.
- 8TRA.DE Traton SE
- A2M.AU The a2 Milk Company Ltd
- AAUC.TO Allied Gold Corporation
- ABB.ST ABB Ltd
- ABEV Ambev SA ADR
- ABVX.PA Abivax SA
- AC.TO Air Canada
- ACA Arcosa Inc
- ACKB.BR Ackermans & Van Haaren NV
- ACLN.SW Accelleron Industries AG
- ACO-X.TO ATCO Ltd
- ACT Enact Holdings Inc
- ACX.MC Acerinox
- AD.AS Koninklijke Ahold Delhaize NV
- ADC Agree Realty Corporation
- AED.BR Aedifica